[PDF] Top 20 MULTIPLE SCLEROSIS Management and Therapy
Has 10000 "MULTIPLE SCLEROSIS Management and Therapy" found on our website. Below are the top 20 most common "MULTIPLE SCLEROSIS Management and Therapy".
MULTIPLE SCLEROSIS Management and Therapy
... Markowitz, Clyde CONTINUUM: Lifelong Learning in Neurology Volume 16(5) Multiple Sclerosis October 2010 pp 90-104. OU Neurology[r] ... See full document
17
Navigating choice in multiple sclerosis management
... beta therapy specific ...given therapy on T2 lesion volume and the rate of whole brain volume change combined may explain 75% of its impact on dis- ability progression ... See full document
8
Multiple Sclerosis: A Review of Existing Therapy and Future Prospects
... Multiple sclerosis EMS) is the most common demyelinating disease of the human central nervous system (CNS). Medline includes over 13000 articles on MS since 1966 that exclude book chapters and other ... See full document
8
Assessing cost-effectiveness in the management of multiple sclerosis
... of 4 immunomodulatory drugs: SC glatiramer acetate and 3 IFN β s: IM IFN β -1a, SC IFN β -1a and SC IFN β -1b. A Markov model populated by data from the literature was developed to assess the cost-effectiveness of 5 ... See full document
18
A gender related action of IFNbeta therapy was found in multiple sclerosis
... Neurology of the University of L’ Aquila. 18 of these patients were receiving IFNβ-therapy (the treated group) and 18 were not (the untreated group). None of the patients had suffered an exacerbation in the 3 ... See full document
17
Assessment of bone marrow derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
... in multiple central nervous system (CNS) path- ways collated as a composite score known as the glo- bal evoked potential (GEP) [2, 3] improved in all patients studied ( n = 6) ... See full document
8
Effects of Self-Care Training on MS Patients’ Hope Rate by Group Discussion
... Group Therapy on Life Expectancy and Hope Rate of Patients with Multiple Sclerosis” shows that the average score of well-being and hope rate in Azemayesh group turned up to be significantly higher ... See full document
5
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial
... and multiple sclerosis functional composite (MSFC) scores; 15 MSFC scores were calculated from the paced auditory serial addition test, the nine-hole peg test, and the timed 25-foot walk ... See full document
14
Identifying responders and nonresponders to interferon therapy in multiple sclerosis
... suggests that on-treatment MRI monitoring is more sensitive than composite scores for early prediction of nonresponse to IFNB. Lastly, a “dose-effect” with regard to new MRI lesions has also been described, ie, the ... See full document
10
Optimization models on management of multiple sclerosis
... The prime function of a nerve cell is to make neurological communication in central nervous system which includes Brain, spinal cord and other peripheral organs of the body. The neuron communication is in the form of ... See full document
6
Role of oral teriflunomide in the management of multiple sclerosis
... on therapy; pharmacokinetics of teriflunomide; associations between variations in genes and clinical outcomes; fatigue and health-related quality of life; and measures of health eco- nomics (hospitalization due to ... See full document
15
Multiple Sclerosis, Physical Therapy, and Quality of Life Insights
... Physical therapy (PT) offers profound benefits to patients with MS in alleviating adverse side effects and improving QoL. PT improves muscle strength, flexibility, and mobility training for daily life activities. ... See full document
8
Effectiveness of Cognitive Behavioral Therapy for Multiple Sclerosis (MS) Fatigue
... energy management [31] to successfully reduce MS fatigue ...behavioral therapy may exert positive and rather consistent influence to decrease the level of fatigue in MS sufferers ... See full document
7
Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot study
... clinical outcomes for existing disease states are major areas of interest for the journal. This journal has been accepted for indexing on PubMed Central. The manuscript management system is completely online and ... See full document
5
The Effect of Mindfulness-Based Stress Reduction (MBSR) Therapy on Quality of Life in Women with Multiple Sclerosis, Ahvaz, Iran
... of Multiple Sclerosis (MS) which can reduce satisfaction with life, as well as increase death ratio and neuro-mental ...(MBSR) therapy on the quality of life in women with Multiple ... See full document
5
The effectiveness of Robot Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial
... Multiple sclerosis (MS) is a chronic inflammatory disease causing widespread degeneration of the central nervous ...physical therapy [4, 12 – 14] and low-to- moderate-intensity aerobic over-ground or ... See full document
12
Therapeutic Applications of Monoclonal Antibodies in Multiple Sclerosis
... Multiple sclerosis (MS) is considered as an autoimmune, chronic and inflammatory condition that leads to degeneration of neurons and abnormal immune responses occurred in the central nervous system ...the ... See full document
15
Human embryonic stem cell for the treatment of multiple sclerosis: A case report
... Introduction: Multiple sclerosis (MS) is a chronic demyelinating disease with inflammatory ...hESC therapy consisted of treatment phases separated by gap ...hESC therapy, there was a ... See full document
5
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence
... MS therapy remains to be clarified in ...beta-1b therapy found that 41% of patients reported new or increased depression within 6 months of starting ... See full document
9
Epstein Barr Virus—The Cause of Multiple Sclerosis
... Multiple Sclerosis (MS) is an unpredictable disease of the central nervous system which disrupts the communi- cation between the brain and other parts of the ...body. Multiple Sclerosis (MS) ... See full document
12
Related subjects